Primary Results Of Ev-301: A Phase Iii Trial Of Enfortumab Vedotin Versus Chemotherapy In Patients With Previously Treated Locally Advanced Or Metastatic Urothelial Carcinoma.

Thomas Powles,Jonathan E. Rosenberg,Guru Sonpavde,Yohann Loriot,Ignacio Duran,Jae-Lyun Lee,Nobuaki Matsubara,Christof Vulsteke,Chunzhang Wu,Mary S. Campbell,Maria Matsangou,Daniel Peter Petrylak

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 12|浏览3

暂无评分

摘要

393Background: Patients with locally advanced or metastatic urothelial carcinoma (la/mUC) have poor survival following progression after platinum-containing chemotherapy and PD-1/L1 inhibitor regim...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要